Antibodies against and kits for detecting anti-mullerian hormone
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- DONGGUAN PENGZHI BIOTECH CO LTD
- Filing Date
- 2020-11-12
- Publication Date
- 2026-07-07
AI Technical Summary
Existing methods for detecting anti-Müllerian hormones suffer from problems such as long processing time, low sensitivity, high false positive and false negative rates, high cost, and unsuitability for small-batch testing. Furthermore, there are few monoclonal antibody products for anti-Müllerian hormones, and their performance varies.
An antibody against Müllerian duct hormone is provided, having a complementary determinant region structure that specifically binds to the anti-Müllerian duct hormone, including CDR-VH1, CDR-VH2, CDR-VH3, CDR-VL1, CDR-VL2 and CDR-VL3, which binds to a specific marker for detection. The preparation method includes recombinant genetics technology and an automated peptide synthesizer.
It achieves highly sensitive and specific detection of anti-Müllerian hormones, provides better antibody selection, is suitable for small-batch testing, reduces costs, and improves detection efficiency and accuracy.
Smart Images

Figure CN114478765B_ABST